Curanex Pharmaceuticals, Inc. (CURX)
4.410
-0.03
(-0.67%)
USD |
NASDAQ |
Nov 20, 16:00
4.44
+0.03
(+0.67%)
After-Hours: 20:00
Curanex Pharmaceuticals Shareholders Equity (Quarterly) : 2.545M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 2.545M |
| June 30, 2026 | 4.788M |
| March 31, 2026 | 8.079M |
| December 31, 2025 | 11.22M |
| September 30, 2025 | 14.29M |
| June 30, 2025 | 0.3054M |
| Date | Value |
|---|---|
| March 31, 2025 | 0.3658M |
| December 31, 2024 | 0.5034M |
| September 30, 2024 | 0.6405M |
| June 30, 2024 | 0.7152M |
| March 31, 2024 | |
| December 31, 2023 | 0.0601M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Breakthrough Chemistry, Inc. | 0.157M |
| Kaya Holdings, Inc. | -0.5474M |
| Cardiac Biotech Solutions, Inc. | -2.320M |
| Endexx Corp. | -- |
| Earth Science Tech, Inc. | 8.054M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.097M |
| Total Liabilities (Quarterly) | 0.5518M |
| Debt to Equity Ratio | 0.213 |
| Current Ratio | 17.84 |
| Net Debt Paydown Yield | -0.17% |